Page last updated: 2024-08-21

adamantane and Alveolitis, Fibrosing

adamantane has been researched along with Alveolitis, Fibrosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gladson, S; Karasawa, S; Nishimura, R; Shimomura, I; Suzuki, T; Tada, Y; Tatsumi, K; West, J	1

Other Studies

1 other study(ies) available for adamantane and Alveolitis, Fibrosing

Article	Year
Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respiratory research, 2017, 10-16, Volume: 18, Issue:1 Topics: Adamantane; Animals; Dipeptidyl-Peptidase IV Inhibitors; Epithelial-Mesenchymal Transition; Lipopolysaccharides; Lung Injury; Male; Mice; Mice, Inbred C57BL; Nitriles; Pulmonary Fibrosis; Pyrrolidines; Vildagliptin	2017

Article

Year

Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.

Respiratory research, 2017, 10-16, Volume: 18, Issue:1

Topics: Adamantane; Animals; Dipeptidyl-Peptidase IV Inhibitors; Epithelial-Mesenchymal Transition; Lipopolysaccharides; Lung Injury; Male; Mice; Mice, Inbred C57BL; Nitriles; Pulmonary Fibrosis; Pyrrolidines; Vildagliptin

2017